Strict glucose control and artificial regulation of the NO-ADMA-DDAH system in order to prevent endothelial dysfunction.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 27246541)

Published in J Physiol on June 01, 2016

Authors

Saskia J H Brinkmann1, E A Wörner1, Paul A M van Leeuwen1

Author Affiliations

1: Department of Surgery, VU University Medical Center, Amsterdam, The Netherlands.

Articles cited by this

Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase. Circulation (2002) 2.65

Modulation of asymmetric dimethylarginine in critically ill patients receiving intensive insulin treatment: a possible explanation of reduced morbidity and mortality? Crit Care Med (2005) 1.58

Ceramide mediates vascular dysfunction in diet-induced obesity by PP2A-mediated dephosphorylation of the eNOS-Akt complex. Diabetes (2012) 1.31

Impairment of PI3-K/Akt pathway underlies attenuated endothelial function in aorta of type 2 diabetic mouse model. Hypertension (2004) 1.22

Vascular insulin resistance in prehypertensive rats: role of PI3-kinase/Akt/eNOS signaling. Eur J Pharmacol (2009) 1.04

The clinical significance of asymmetric dimethylarginine. Annu Rev Nutr (2006) 0.99

Preserved endothelial function in human obesity in the absence of insulin resistance. J Transl Med (2013) 0.93

Asymmetric dimethylarginine and critical illness. Curr Opin Clin Nutr Metab Care (2014) 0.88

Asymmetric dimethylarginine (ADMA) elevation and arginase up-regulation contribute to endothelial dysfunction related to insulin resistance in rats and morbidly obese humans. J Physiol (2016) 0.88

The Arginine/ADMA Ratio Is Related to the Prevention of Atherosclerotic Plaques in Hypercholesterolemic Rabbits When Giving a Combined Therapy with Atorvastatine and Arginine. Int J Mol Sci (2015) 0.83

Modulating DDAH/NOS Pathway to Discover Vasoprotective Insulin Sensitizers. J Diabetes Res (2015) 0.81